4 results  1 of 1 

1 Update on Modern Management of Pheochromocytoma and Paraganglioma
Jacques W. M. Lenders, Graeme Eisenhofer
Endocrinol Metab.2017;32(2):152-161.   Published online 2017 June 23     DOI: http://dx.doi.org/10.3803/EnM.2017.32.2.152
      
2 A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion
Camilla Schalin-Jäntti, Merja Raade, Esa Hämäläinen, Timo Sane
Endocrinol Metab.2015;30(4):481-487.   Published online 2015 December 31     DOI: http://dx.doi.org/10.3803/EnM.2015.30.4.481
      
3 Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Quantification of Plasma Metanephrines for Differential Diagnosis of Adrenal Incidentaloma
Sae-Mi Lee, Mi-Na Lee, Hyeon Ju Oh, Yoon Young Cho, Jae Hyeon Kim, Hye In Woo, Hyung-Doo Park, Soo-Youn Lee
Ann Lab Med.2015;35(5):519-522.   Published online 2015 July 15     DOI: http://dx.doi.org/10.3343/alm.2015.35.5.519
      
4 Diagnostic Value of 24-hours Urinary Total Metanephrine As a Screening Test of Patients with Suspected Pheochromocytoma
Sang Wan Kim, Kyung Won Kim, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee
J Korean Soc Endocrinol.2005;20(1):12-20.   Published online 2005 February 20     DOI: http://dx.doi.org/10.3803/jkes.2005.20.1.12
      

 1 of 1